Although the prevalence of TP53 mutations in adult cohorts of ACC patients was considerably lower, loss of heterozygosity of the P53 gene at locus 17p13 is reported in 85% of sporadic ACC [146], implicating that TP53 is not the only tumor suppressor gene at that specific locus [154]. Here, TP53 is linked to adrenal cortex carcinoma.